On April 11, 2024, Merck & Co., Inc announced that it has received a shareholder proposal from National Legal and Policy Center requesting the Company Board to provide a report, published on the Company website and updated at reasonable intervals omitting proprietary information and at reasonable cost that specifies the Company?s policy in response to requests, whether from agencies of the United States Government or from state governments, to aid censorship. In addition, the Company urged the shareholders to vote against the proposal at its annual general meeting of shareholders scheduled to be held on May 28, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.9 USD | -1.01% | +2.47% | +19.31% |
04:14pm | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
08:52am | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.35% | 332B | |
+25.97% | 661B | |
+26.74% | 566B | |
-6.65% | 352B | |
+3.35% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.22% | 145B | |
-10.81% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co Receives a Shareholder Proposal from National Legal and Policy Center